beta-Lactamase Inhibitors

Preferred Label : beta-Lactamase Inhibitors;

MeSH definition : Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.;

MeSH synonym : Inhibitors, beta-Lactamase; beta Lactamase Inhibitors; Inhibitors, beta Lactamase; Lactamase Inhibitors, beta; beta Lactamase Antagonists; Antagonists, beta Lactamase; Lactamase Antagonists, beta; beta Lactamase Inhibitor; Inhibitor, beta Lactamase; Lactamase Inhibitor, beta; beta-Lactamase Inhibitor; Inhibitor, beta-Lactamase;

Wikipedia link : https://en.wikipedia.org/wiki/Beta lactamase inhibitor;

Is substance : O;

Details

Origin ID

D065093;

UMLS CUI

C3810840;

ATC code(s)
- cefpodoxime and beta-lactamase inhibitor [ATC Code]
ATC code(s)
- amoxicillin and beta-lactamase inhibitor [ATC Code]
- ampicillin and beta-lactamase inhibitor [ATC Code]
- aztreonam and beta-lactamase inhibitor [ATC Code]
- cefepime and beta-lactamase inhibitor [ATC Code]
- cefixime and beta-lactamase inhibitor [ATC Code]
- cefoperazone and beta-lactamase inhibitor [ATC Code]
- cefotaxime and beta-lactamase inhibitor [ATC Code]
- cefpodoxime and beta-lactamase inhibitor [ATC Code]
- ceftazidime and beta-lactamase inhibitor [ATC Code]
- ceftolozane and beta-lactamase inhibitor [ATC Code]
- ceftriaxone and beta-lactamase inhibitor [ATC Code]
- cefuroxime and beta-lactamase inhibitor [ATC Code]
- piperacillin and beta-lactamase inhibitor [ATC Code]
- ticarcillin and beta-lactamase inhibitor [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Beta-lactamase Inhibitor [NCIt concept]
- beta-lactamase inhibitors [CISMeF Querying Strategy]
MeSH Descriptor(s) used for indexing
- beta-Lactamases [MeSH Descriptor]
- cephalosporinase [MeSH Descriptor]
- penicillinase [MeSH Descriptor]
Record concept(s)
- beta-Lactamase Inhibitors [MeSH concept]
See also inter- (CISMeF)
- Beta-lactamase inhibitor (disposition) [SNOMED CT concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
Substance(s)
- (1S,5R)-(((4S)-azepan-4-ylamino)carbonyl)-7-oxo-2,6-diazabicyclo(3.2.0)heptane-6-sulfonic acid [MeSH Supplementary Concept]
- 1-(4-methoxyphenyl)-3-acetamido-4-methoxyazetidin-2-one [MeSH Supplementary Concept]
- 2,2-dimethylpenam sulfone [MeSH Supplementary Concept]
- 2-((4-pyridiniummethyl)-1,2,3-triazol-1-yl)methyl-6,6-dihydropenicillanate 1,1-dioxide [MeSH Supplementary Concept]
- 2-(ethoxycarbonyl)-6,6-dihydropenicillanic acid [MeSH Supplementary Concept]
- 3-(2'-benzyl-3'-mercaptopropanoyl)-4-carboxy-5, 5-dimethylthiazolidine [MeSH Supplementary Concept]
- 3-(2-cyanoethenyl)-3-methyl-4,4,7-trioxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid [MeSH Supplementary Concept]
- 3-carboxyphenyl phenylacetamidomethylphosphonate [MeSH Supplementary Concept]
- 3-carboxyphenyl((N-((4-iodophenyl)acetyl)amino)methyl)phosphonate [MeSH Supplementary Concept]
- 3-chloro-3',3'-dimethyl-7'-oxo-3-((phenylamino)carbonyl)spiro(oxirane-2,6'-(4)thia(1)azabicyclo(3.2.)heptane)-2'-carboxylic acid [MeSH Supplementary Concept]
- 3-hydroxy-2-methyl-4H-pyran-4-thione [MeSH Supplementary Concept]
- 4-(3-amido-4-phenyl-2-azetidinonyl)-1-acetophenone [MeSH Supplementary Concept]
- 4-(3-amido-4-phenyl-2-azetidinonyl)-1-phenylacetic acid [MeSH Supplementary Concept]
- 4-(3-amino-2-oxoazetidinonyl-1)methylbenzoic acid [MeSH Supplementary Concept]
- 4-(3-amino-2-oxoazetidinonyl-1)methylcyclohexanecarboxylic acid [MeSH Supplementary Concept]
- 6,6-bis(hydroxylmethyl)penicillanate [MeSH Supplementary Concept]
- 6-((4-nitrobenzyloxycarbonyl)methylsulfonamido)penicillanic acid sulfone [MeSH Supplementary Concept]
- 6-((anilinocarbonyl)methylsulfonamido)penicillanic acid sulfone [MeSH Supplementary Concept]
- 6-((biotinyl-N-epsilon-aminocaproyl-N-cystamine-N'-carbonyl)methylsulfonyl)aminopenicillanic acid S,S-dioxide [MeSH Supplementary Concept]
- 6-((carboxy)methylsulfonamido)penicillanic acid sulfone [MeSH Supplementary Concept]
- 6-(1-(1-(2-(2-phenyl-1,3,4-thiadiazol-5-yl)thioethyl)-1,2,3-triazol-4-yl)methylene)penicillanic acid [MeSH Supplementary Concept]
- 6-(1-(1-(2--(2-phenyl-1,3,4-thiadiazol-5-yl)sulfonylethyl)-1,2,3-triazol-4-yl)methylene)penicillanic acid [MeSH Supplementary Concept]
- 6-(1-hydroxy)benzylpenicillanic acid S,S-dioxide [MeSH Supplementary Concept]
- 6-(biotinyl-N-epsilon-aminocaproyl-N-cystamine-N'-glutaryl)aminopenicillanic acid [MeSH Supplementary Concept]
- 6-(methyoxymethylene)penicillanic acid [MeSH Supplementary Concept]
- 6-acetylmethylenepenicillanic acid [MeSH Supplementary Concept]
- 6-beta-(trifluoromethanesulfonyl)amido-penicillanic acid sulfone [MeSH Supplementary Concept]
- 6-chloro-2-chloromethyl-2-methylpenam-3-carboxylic acid 1,1-dioxide [MeSH Supplementary Concept]
- 6-iodopenicillanic acid [MeSH Supplementary Concept]
- 6-methyl-2-aminopyridine palladium dichloride [MeSH Supplementary Concept]
- 6-sulfoaminopenicillanic acid [MeSH Supplementary Concept]
- 8-oxo-7-(2-oxo-2H-chromene-3-carboxamido)-3-((4-(2-oxo-2H-chromene-3-carboxamido)-phenylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid [MeSH Supplementary Concept]
- 9-N-isobutylaminodeoxyclavulanate [MeSH Supplementary Concept]
- 9-O-methylclavulanate [MeSH Supplementary Concept]
- AM 113 [MeSH Supplementary Concept]
- AM 114 [MeSH Supplementary Concept]
- AM 115 [MeSH Supplementary Concept]
- AVE 1330A [MeSH Supplementary Concept]
- BL-P 2013 [MeSH Supplementary Concept]
- BL-P 2090 [MeSH Supplementary Concept]
- BLI-489 [MeSH Supplementary Concept]
- C6-(N1-methyl-1,2,3-trazolylmethylene)penem [MeSH Supplementary Concept]
- CH 1240 [MeSH Supplementary Concept]
- CH 2140 [MeSH Supplementary Concept]
- KA-107 [MeSH Supplementary Concept]
- L 159906 [MeSH Supplementary Concept]
- LN 1-255 [MeSH Supplementary Concept]
- MK 8712 [MeSH Supplementary Concept]
- N-(2'-mercaptoethyl)-2-phenylacetamide [MeSH Supplementary Concept]
- N-tosyloxy-3-phthalimido-4-methyl-2-azetidinone [MeSH Supplementary Concept]
- N-tosyloxy-4-phenyl-2-azetidinone [MeSH Supplementary Concept]
- Piperacillin, Tazobactam Drug Combination [MeSH Descriptor]
- QPX7728 [MeSH Supplementary Concept]
- SB 202742 [MeSH Supplementary Concept]
- SK&F 96464 [MeSH Supplementary Concept]
- SYN 1012 [MeSH Supplementary Concept]
- Tazobactam [MeSH Descriptor]
- ZINC03787097 [MeSH Supplementary Concept]
- amoxicillin-potassium clavulanate combination [MeSH Descriptor]
- avibactam [MeSH Supplementary Concept]
- avibactam, ceftazidime drug combination [MeSH Supplementary Concept]
- benzo(b)thiophene-2-boronic acid [MeSH Supplementary Concept]
- benzo(b)thiophene-2-ylboronic acid [MeSH Supplementary Concept]
- beta-lactamase-inhibitor protein, streptomyces [MeSH Supplementary Concept]
- brobactam [MeSH Supplementary Concept]
- ceftolozane, tazobactam drug combination [MeSH Supplementary Concept]
- clavulanic acid [MeSH Descriptor]
- dotriacolide [MeSH Supplementary Concept]
- durlobactam [MeSH Supplementary Concept]
- enmetazobactam [MeSH Supplementary Concept]
- isatoic anhydride [MeSH Supplementary Concept]
- izumenolide [MeSH Supplementary Concept]
- levonadifloxacin [MeSH Supplementary Concept]
- methylene-6-(3-formylallylidene)penicillanate pivalate [MeSH Supplementary Concept]
- olivacins [MeSH Supplementary Concept]
- phenylpropynal [MeSH Supplementary Concept]
- pluracidomycin [MeSH Supplementary Concept]
- relebactam [MeSH Supplementary Concept]
- ro 48-1220 [MeSH Supplementary Concept]
- ro 48-1256 [MeSH Supplementary Concept]
- ro 48-5545 [MeSH Supplementary Concept]
- ro 48-8724 [MeSH Supplementary Concept]
- sulbactam [MeSH Descriptor]
- syn 2190 [MeSH Supplementary Concept]
- thiomandelic acid [MeSH Supplementary Concept]
- ticarcillin-clavulanic acid [MeSH Supplementary Concept]
- vaborbactam [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Beta-lactamase Inhibitor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients